US high court rules against Amgen in class action
WASHINGTON Feb 27 (Reuters) - The U.S. Supreme Court made it easier on Wednesday to bring class action lawsuits, breaking a line of rulings that had made it more difficult to sue corporate defendants collectively and perhaps obtain greater recoveries.
The case against Amgen Inc concerned what kind of evidence must be presented before companies may be the subject of class action lawsuits.
By 6-3, the court allowed a suit against Amgen to go forward in which the Connecticut Retirement Plans and Trust Funds accuses the biotechnology company of fraudulently inflating its stock price.
- Exclusive: Angry with Washington, 1 in 4 Americans open to secession
- Secret Service investigates after man jumps White House fence, reaches doors
- About 60,000 Syrian Kurds flee to Turkey as Islamic State advances |
- French jets strike in Iraq, expanding U.S.-led campaign against Islamic State |
- Scots spurn independence in historic vote, devolution battle begins |